Crossmark

Anti-drug Antibody Magnitude and Clinical Relevance Using Signal to Noise (S/N): Bococizumab Case Study

Published Online: 2023-09-02

Authors

McCush, Fred

Wang, Ellen

Yunis, Carla

Schwartz, Pamela

Baltrukonis, Daniel
License Information

Text and Data Mining valid from 2023-09-02

Version of Record valid from 2023-09-02
More Information

Article History

Received: 1 June 2023

Accepted: 31 July 2023

First Online: 2 September 2023

Declarations

:

: This study was funded by Pfizer, Inc. All the authors listed are employees of the Pfizer, Inc.

Document is current